title: Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens.
authors.affiliation: Immune Deficiency Treatment Centre, Montreal General Hospital, McGill University, Montreal, Que., Canada.
authors.forename: Mona R
authors.initials: MR
authors.lastname: Loutfy
authors.forename: Janet M
authors.initials: JM
authors.lastname: Raboud
authors.forename: Sharon L
authors.initials: SL
authors.lastname: Walmsley
authors.forename: Refik
authors.initials: R
authors.lastname: Saskin
authors.forename: Julio S
authors.initials: JS
authors.lastname: Montaner
authors.forename: Robert S
authors.initials: RS
authors.lastname: Hogg
authors.forename: Courtney A
authors.initials: CA
authors.lastname: Thompson
authors.forename: P Richard
authors.initials: PR
authors.lastname: Harrigan
mesh_terms: D000328:Adult; D002170:Canada; D015331:Cohort Studies; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D016333:HIV Protease / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D016015:Logistic Models; D061466:Lopinavir; D008297:Male; D015999:Multivariate Analysis; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D016879:Salvage Therapy
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D016333:HIV Protease; D019438:Ritonavir